Intraosseous Infusion Devices Market
Market Insights on Intraosseous Infusion Devices covering sales outlook, demand forecast & up-to-date key trends
Intraosseous Infusion Devices Market by Product (B.I.G, FAST1, EZ-IO, FASTR, IO Needles), Route of Administration (Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus, Head of Humerus), Technology (Manual, Automatic), End User & Region - Forecast to 2021 - 2031
Intraosseous Infusion Devices Market Snapshot
[193 Pages Report] According to Future Market Insights (FMI), the global intraosseous infusion device was valued at US$ 3.5 Bn in 2020 and is expected to reach US$ 7.9 Bn by 2031, at a CAGR of 7.6% over the forecast period (2021-2031).
Amidst soaring competition, Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Beckon Dickinson and Co. have emerged as top market players. FMI has projected these companies to account for over half of the global market share in 2021.
Market Outlook:
|
Data Points |
Market Insights |
|
Intraosseous Infusion Market Value 2020 |
US$ 3.5 Bn |
|
Intraosseous Infusion Market Value 2031 |
US$ 7.9 Bn |
|
CAGR 2021-2031 |
7.6% |
|
Share of Top 5 countries |
51% |
|
Key Players |
Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Beckon Dickinson and Co. |
Let us know your requirement to get
100% FREE customization
How will the Intraosseous Infusion Market Outlook for 2021-2031 compare to 2016-2020?
According to Future Market Insights (FMI), the sales of the intraosseous infusion device have grown at a CAGR of nearly 5.6% between 2016 and 2020. Increasing research on emergency medical care portfolio globally will result in impressive sales prospects over the coming years.
According to FMI, the intraosseous infusion devices market holds nearly 19% of the US$ 18.5 Bn worth global market for infusion devices. The demand for intraosseous devices will continue increasing through the forecast period.
For instance, air support for immediate medical emergency services is the new outlook in 911 services and has been appreciated by the other emergency health professionals and the local population.
The upcoming air emergency medical service is to be equipped with a variety of emergency medical devices such as a ventilator, cardiac monitor, burn packs, IV pumps, cervical collars and obstetric kit along with intraosseous infusion devices.
The upcoming policy is expected to drive the intraosseous infusion devices market. Infusion of drugs through the bone using intraosseous devices is more cost-effective and can be done more efficiently as compared to intravenous catheters in hospital settings.
Manufacturers are investing in research and development activities to develop IO devices that can be used in hospital settings to initiate instant care to patients. Mergers and acquisitions together with extensive R&D initiatives for strengthening product portfolio are key strategies adopted by companies to increase their revenue.
For Instance, On Dec 18, Cook Medical Incorporated announced the acquisition of Whitaker Park Development Authority Inc. that once manufactured cigarettes but henceforth will be manufacturing intraosseous infusion devices for better care of the patients.
The market is consolidated and is dominated by players such as include, Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.
Future Market Insights expects the global market for intraosseous infusion devices to grow at a CAGR of 7.6% between 2021 and 2031. The growth is attributable to the rising number of research and development activities undertaken by market players to expand their presence and strengthen product portfolios.
How is Rising Demand for Emergency Healthcare Affecting Intraosseous Infusion Devices Market?
IO Devices are designed to maximize efficiency, safety, eliminate unnecessary services and decrease treatment time. A sedentary lifestyle has also determined the growth of the market as it causes various illnesses which incudes, last stage renal diseases, COPD, urological diseases, cardiovascular diseases, etc. Such chronic clinical conditions have brought demand in the vascular access devices in the forecast period.
Emergency medical care is considered as pre-hospital or ambulatory transportation aid for road accident victims and those who have sustained life-threatening injuries for which, immediate medical intervention is required. Lack of structural models in medical aid leads to ineffective medical care. These factors, along with the rising number of emergency cases globally is expected to raise demand for efficient emergency medical services and in turn, is underpinning the intraosseous infusion device market.
According to the American Heart Association report, 2015, compiled with data from the Centers for Disease Control and Prevention, the National Institutes of Health and other government sources, cardiovascular disease is the leading cause for death globally, associated with 17.3 Mn deaths per year, which is further expected to increase to 23.6 Mn by 2030 end.
Vascular access products fill an important void in emergency medical services and contribute significantly towards the annual revenue of various major medical devices manufacturers. The ease and immediate effect through vascular access have helped considerably high number of patients requiring immediate medication intervention.
According to an Elsevier/Journal of Emergency Medical Services (JEMS) editorial supplement sponsored by VidaCare, IO infusion supported vascular access of drugs positively and provided rapid vascular access in 250 patients with a success rate of 97%. The study supports the significance of the need for vascular access and is expected to favour the growth of the intraosseous infusion market shortly
Over the recent years, there has been a significant upsurge in the number of emergency medical cases in response to rising demand from patients, physicians and insurers. Rapid technological advancements have led to various medical procedures being carried out using vascular access devices.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow is The Rising Number of Traumatic Surgeries Affecting Intraosseous Infusion Devices Market Growth?
There are two components involved in community care, care during transportation and care in the healthcare facility. In emergency medical departments a patient can be brought in a severe life threatening condition, be it severe burns, road traffic accidents or cardiac arrest, where sometimes it is difficult to find for an IV point or it becomes difficult when the venous system is collapsed. This in turn is need for intraosseous infusion devices in the market.
A rising number of traumatic surgeries especially in pediatric patients has been reported in the past few decades, which is further expected to support the intraosseous infusion devices based market growth.
According to the Royal College of Surgeons, 2014, a document on emergency surgery policy briefing states that approximately 25% of patients were admitted in an emergency in 2012-2013 with 32% of trauma and orthopaedic surgery collectively. The rate of patient readmission increased by 27.1% from 2002-03 to reach 11.5% in 2012-13
The American College of Surgeons Advanced Trauma Life Support Manual (ATLS) 1997, has suggested the use of intraosseous infusion in children up to 6 years of age during traumatic situations like a circulatory failure or after two failed attempts of intravenous access.
What is the Impact of the COVID-19 Crisis on the Market?
Due to COVID 19, there has been a gradual rise in the market growth across intraosseous infusion devices segment. During the pandemic, there has been an increase in the number of emergency medical services where instant treatment was necessary. Furthermore, clinical conditions that needed instant care/ attention such as severe burns, accidents or trauma where IV access is not possible at that particular time and IO devices helps rapid infusion of fluids and medicines. This has let the demand for IO devices to boost.
Narayana health org. in July 2020 stated that stroke can be a manifestation whilst covid-19 and 0.9% to 23% COVID-19 patients developed stroke. Hemorrhagic and ischemic stroke are the types of stroke seen in Covid-19 patients.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Insights
Will the U.S. Intraosseous Infusion Devices Market Continue Leading North America?
In 2021, the U.S. is estimated to account for over 53.1% value share in North America. The demand is increasing in the U.S due to the increasing number of emergency medical cases that focus on delivering the highest quality and instant care to the patients.
Why is Russia Intraosseous Infusion Devices Market Considered Highly Lucrative within Europe?
Russia is expected to account for nearly 14.3% of the market in Europe. The rise in demand for intraosseous infusion devices in Russia is primarily due to the increasing aging population, rising cases of chronic diseases and presence of well-established centers which provide quality care. Furthermore, favorable regulatory scenarios are likely to offer exciting opportunities for the intraosseous infusion device in Russia.
What are the Factors Supporting Intraosseous Infusion Devices Sales in China?
The China market is expected to account for over 38.0% of the market share in East Asia through the forecast period. The increasing use of IO Devices, with advancement in technology, expansion of the healthcare industry, and the rising need for efficient and safe healthcare practices and other therapeutics are the primary factors driving growth in China.
Sales in China are also influenced by domestic market impact factors such as regulatory change, favorable government policies and growing funding which affects current and future market trends.
Category-wise Insights
Why is the demand for EZ-IO Product Rising?
In terms of product, EZ-IO intraosseous infusion devices hold the maximum share of over 20% in 2021, expanding at 7.6% CAGR during the forecast period. Growth registered in this category is due to its quick response and surety of easy intraosseous accessibility within 30 seconds.
Why is Sternum Route of Administration Preferred in Intraosseous Infusion Devices Market?
In terms of route of administration, the Sternum segment accounts for 30.8% of the market share in 2021, indicating prevalence of high demand for high-quality care specificity when compared with the Distal & Proximal Tibia. This trend is expected to continue during the forecast period as well.
How Will Sales of Automatic Intraosseous Infusion Devices Fare?
By technology, the automatic infusion devices market accounts for 50.8% of the market share in 2021. The demand in this segment will continue rising. It is primarily preferred by the patients when they need instant care.
Who is the Leading End User of Intraosseous Infusion Devices?
By end user, EMS and hospitals together will account for more than 60.0% of the market share in 2021. The rising demand for IO devices with various advancements and harnessing new scientific advances is likely to fuel the segment.
Competitive Landscape
Companies manufacturing intraosseous infusion devices are actively seeking to strengthen their position through various strategic planning such as collaborations, merger & acquisition partnerships, FDA approvals and agreements with established as well as emerging market players. These strategies will help manufacturers capitalize on available opportunities in the market:
In July 2020, Aero Healthcare acquired Clayton First Aid creating a window where they can expand themselves into intraosseous infusion devices
The greater the demand for active service, the stronger is the end product, which will lead to increased demand for the market. Leading industry players are focusing on the development and launch of the technologically advanced service portfolio. There are huge opportunities for the market players to invest in intraosseous infusion device s
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
USD Million for Value. |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
|
Key Segments Covered |
Product, Route of Administration, Technology, End User and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Intraosseous Infusion Devices - Market by Category
Product:
- B.I.G
- FAST1
- EZ-IO
- FASTR
- IO Needles
- Others
By Route of Administration:
- Sternum
- Distal & Proximal Tibia
- Distal Femur
- Calcaneus
- Head of Humerus
By Technology:
- Manual
- Automatic
- Impact Driven
- Power Drill
By End User:
- EMS
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Care Centers
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The market is expected to grow from US$ 3.8 Bn in 2021 to US$ 7.9 Bn in 2031, rising at a CAGR of 7.6% over the forecast period (2021-2031).
The global intraosseous infusion device market is projected to be driven by the increasing demand for vascular access devices and quality emergency care.
North America currently holds the dominant share of 26.6% in the intraosseous infusion devices market.
The intraosseous infusion devices market in ASEAN is likely to grow at a CAGR of 7.0% during the forecast period, from 2021 to 2031.
The primary focus for emergency settings is to stabilize the patient from a life-threatening event and refer them to a primary healthcare center immediately for further desired medical intervention. To support this, governments across various countries around the world are prioritizing emergency attention for raising healthcare standards. Improvement in standards of pre-hospital emergency settings in developing countries is driving the intraosseous infusion device.
The Japan market is expected to exhibit healthy growth at 7.4% CAGR during the forecast period.
U.S., Canada, Japan, China, and Russia are the top 5 countries that are driving the demand for Intraosseous infusion device s.
Leading companies offering intraosseous infusion devices are Pyng medical Corp., Cook Medical Incorporated, PerSys Medical, Aero Healthcare, Teleflex, Inc., and Becton Dickinson and Co.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Technology Roadmap
3.3. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Growth Outlook
4.1.2. Global Healthcare Outlook
4.1.3. Per Capita Healthcare Expenditure Outlook
4.2. Forecast Factors - Relevance & Impact
4.2.1. Increasing Emergency medical cases
4.2.2. Increase in cardiovascular disease
4.2.3. Advancements in Intraosseous infusion devices
4.2.4. Adoption Rate for Intraosseous infusion devices
4.3. Value Chain
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 Economic analysis
5.4. COVID19 and Impact Analysis, by Country
5.5. 2020 Market Scenario
6. Key Success Factors
6.1. Product Adoption & Awareness Analysis
6.2. Product USPs / Features
6.3. Recent Product Launches
6.4. Value Chain Analysis
6.5. Key Promotion Strategies by Manufacturers
7. Market Demand (in Volume ‘000 Units) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Volume (‘000 Units) Analysis, 2016-2020
7.2. Current and Future Market Volume (‘000 Units) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Intraosseous Infusion Devices Market Pricing Analysis
8.1. Regional Pricing Analysis , By Product
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Intraosseous Infusion Devices Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
9.2. Current and Future Market Value (In Value or Size in US$ Mn) Projections, 2021-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (‘000 Units) Analysis By Product, 2016-2020
10.3. Current and Future Market Size (US$ Mn) and Volume (‘000 Units) Forecast By Product , 2021-2031
10.3.1. B.I.G
10.3.2. FAST1
10.3.3. EZ-IO
10.3.4. FASTR
10.3.5. IO Needles
10.3.6. Others
10.4. Market Attractiveness Analysis By Product
11. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2016-2020
11.3. Current and Future Market Size (US$ Mn) and Forecast By Route of Administration , 2021-2031
11.3.1. Sternum
11.3.2. Distal & Proximal Tibia
11.3.3. Distal Femur
11.3.4. Calcaneus
11.3.5. Head of Humerus
11.4. Market Attractiveness Analysis By Route of Administration
12. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Technology
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Technology, 2016-2020
12.3. Current and Future Market Size (US$ Mn) and Forecast By Technology , 2021-2031
12.3.1. Manual
12.3.2. Automatic
12.3.3. Impact Driven
12.3.4. Power Drill
Market Attractiveness Analysis By Technology
13. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By End user
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2020
13.3. Current and Future Market Size (US$ Mn) and Forecast By End User , 2021-2031
13.3.1. EMS
13.3.2. Hospitals
13.3.3. Ambulatory Surgical Centers
13.3.4. Cardiac Care Centers
13.4. Market Attractiveness Analysis By End User
14. Global Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031, By Region
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020
14.3. Current and Future Market Size (US$ Mn) and Forecast By Region , 2021-2031
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. South Asia
14.3.5. East Asia
14.3.6. Oceania
14.3.7. MEA
14.4. Market Attractiveness Analysis By Region
15. North America Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units)Trend Analysis by Market Taxonomy, 2016-2020
15.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Product
15.3.3. By Route of Administration
15.3.4. By Technology
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Route of Administration
15.4.4. By Technology
15.4.5. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Latin America Intraosseous Infusion Devices Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units)Trend Analysis by Market Taxonomy, 2016-2020
16.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product
16.3.3. By Route of Administration
16.3.4. By Technology
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Route of Administration
16.4.4. By Technology
16.4.5. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Europe Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020
17.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units)Forecast by Market Taxonomy, 2021-2031
17.3.1. By Country
17.3.1.1. U.K
17.3.1.2. Germany
17.3.1.3. France
17.3.1.4. Italy
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Product
17.3.3. By Route of Administration
17.3.4. By Technology
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Route of Administration
17.4.4. By Technology
17.4.5. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. South Asia Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020
18.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Thailand
18.3.1.3. Indonesia
18.3.1.4. Malaysia
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Route of Administration
18.3.4. By Technology
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Route of Administration
18.4.4. By Technology
18.4.5. By End User
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. East Asia Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020
19.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product
19.3.3. By Route of Administration
19.3.4. By Technology
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Route of Administration
19.4.4. By Technology
19.4.5. By End User
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Oceania Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031
20.1. Introduction
20.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020
20.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product
20.3.3. By Route of Administration
20.3.4. By Technology
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Route of Administration
20.4.4. By Technology
20.4.5. By End User
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Middle East and Africa Intraosseous Infusion Devices Market 2016-2020 and Forecast 2021-2031
21.1. Introduction
21.2. Historical Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Trend Analysis by Market Taxonomy, 2016-2020
21.3. Market Size In Value or Size (in US$ Mn) and Volume (in ‘000 Units) Forecast by Market Taxonomy, 2021-2031
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. South Africa
21.3.1.3. Rest of Middle East and Africa
21.3.2. By Product
21.3.3. By Route of Administration
21.3.4. By Technology
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Route of Administration
21.4.4. By Technology
21.4.5. By End User
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis
22. Emerging & Key Countries Intraosseous Infusion Devices Market Analysis – 2021 & 2031
22.1. Introduction
22.1.1. Market Value Proportion Analysis, By Key Countries
22.1.2. Global Vs. Country Growth Comparison
22.2. U.S. Intraosseous Infusion Devices Market Analysis
22.2.1. By Product
22.2.2. By Route of Administration
22.2.3. By Technology
22.2.4. By End User
22.3. Canada Intraosseous Infusion Devices Market Analysis
22.3.1. By Product
22.3.2. By Route of Administration
22.3.3. By Technology
22.3.4. By End User
22.4. Mexico Intraosseous Infusion Devices Market Analysis
22.4.1. By Product
22.4.2. By Route of Administration
22.4.3. By Technology
22.4.4. By End User
22.5. Brazil Intraosseous Infusion Devices Market Analysis
22.5.1. By Product
22.5.2. By Route of Administration
22.5.3. By Technology
22.5.4. By End User
22.6. Germany Intraosseous Infusion Devices Market Analysis
22.6.1. By Product
22.6.2. By Route of Administration
22.6.3. By Technology
22.6.4. By End User
22.7. Italy Intraosseous Infusion Devices Market Analysis
22.7.1. By Product
22.7.2. By Route of Administration
22.7.3. By Technology
22.7.4. By End User
22.8. France Intraosseous Infusion Devices Market Analysis
22.8.1. By Product
22.8.2. By Route of Administration
22.8.3. By Technology
22.8.4. By End User
22.9. U.K. Intraosseous Infusion Devices Market Analysis
22.9.1. By Product
22.9.2. By Route of Administration
22.9.3. By Technology
22.9.4. By End User
22.10. Spain Intraosseous Infusion Devices Market Analysis
22.10.1. By Product
22.10.2. By Route of Administration
22.10.3. By Technology
22.10.4. By Technology
22.10.5. By End User
22.11. BENELUX Intraosseous Infusion Devices Market Analysis
22.11.1. By Product
22.11.2. By Route of Administration
22.11.3. By Technology
22.11.4. By End User
22.12. Russia Intraosseous Infusion Devices Market Analysis
22.12.1. By Product
22.12.2. By Route of Administration
22.12.3. By Technology
22.12.4. By End User
22.13. China Intraosseous Infusion Devices Market Analysis
22.13.1. By Product
22.13.2. By Route of Administration
22.13.3. By Technology
22.13.4. By End User
22.14. Japan Intraosseous Infusion Devices Market Analysis
22.14.1. By Product
22.14.2. By Route of Administration
22.14.3. By Technology
22.14.4. By End User
22.15. South Korea Intraosseous Infusion Devices Market Analysis
22.15.1. By Product
22.15.2. By Route of Administration
22.15.3. By Technology
22.15.4. By End User
22.16. India Intraosseous Infusion Devices Market Analysis
22.16.1. By Product
22.16.2. By Route of Administration
22.16.3. By Technology
22.16.4. By End User
22.17. ASEAN Intraosseous Infusion Devices Market Analysis
22.17.1. By Product
22.17.2. By Route of Administration
22.17.3. By Technology
22.17.4. By End User
22.18. Australia and New Zealand Intraosseous Infusion Devices Market Analysis
22.18.1. By Product
22.18.2. By Route of Administration
22.18.3. By Technology
22.18.4. By End User
22.19. GCC Countries Intraosseous Infusion Devices Market Analysis
22.19.1. By Product
22.19.2. By Route of Administration
22.19.3. By Technology
22.19.4. By End User
22.20. Turkey Intraosseous Infusion Devices Market Analysis
22.20.1. By Product
22.20.2. By Route of Administration
22.20.3. By Technology
22.20.4. By End User
22.21. South Africa Intraosseous Infusion Devices Market Analysis
22.21.1. By Product
22.21.2. By Route of Administration
22.21.3. By Technology
22.21.4. By End User
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
23.3.1. By Regional Footprint of Players
23.3.2. Product Footprint by Players
23.3.3. Channel Footprint by Players
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
24.3.1. Pyng medical Corp.,
24.3.1.1. Overview
24.3.1.2. Type Portfolio
24.3.1.3. Sales Footprint
24.3.1.4. Analyst commentary
24.3.1.5. Strategy Overview
24.3.1.5.1. Marketing Strategy
24.3.1.5.2. Product Strategy
24.3.1.5.3. Channel Strategy
24.3.2. Cook Medical Incorporated
24.3.2.1. Overview
24.3.2.2. Type Portfolio
24.3.2.3. Sales Footprint
24.3.2.4. Analyst commentary
24.3.2.5. Strategy Overview
24.3.2.5.1. Marketing Strategy
24.3.2.5.2. Product Strategy
24.3.2.5.3. Channel Strategy
24.3.3. PerSys Medical
24.3.3.1. Overview
24.3.3.2. Type Portfolio
24.3.3.3. Sales Footprint
24.3.3.4. Analyst commentary
24.3.3.5. Strategy Overview
24.3.3.5.1. Marketing Strategy
24.3.3.5.2. Product Strategy
24.3.3.5.3. Channel Strategy
24.3.4. Aero Healthcare
24.3.4.1. Overview
24.3.4.2. Type Portfolio
24.3.4.3. Sales Footprint
24.3.4.4. Analyst commentary
24.3.4.5. Strategy Overview
24.3.4.5.1. Marketing Strategy
24.3.4.5.2. Product Strategy
24.3.4.5.3. Channel Strategy
24.3.5. Teleflex, Inc.
24.3.5.1. Overview
24.3.5.2. Type Portfolio
24.3.5.3. Sales Footprint
24.3.5.4. Analyst commentary
24.3.5.5. Strategy Overview
24.3.5.5.1. Marketing Strategy
24.3.5.5.2. Product Strategy
24.3.5.5.3. Channel Strategy
24.3.6. Becton Dickinson and Co.
24.3.6.1. Overview
24.3.6.2. Type Portfolio
24.3.6.3. Sales Footprint
24.3.6.4. Analyst commentary
24.3.6.5. Strategy Overview
24.3.6.5.1. Marketing Strategy
24.3.6.5.2. Product Strategy
24.3.6.5.3. Channel Strategy
25. Assumptions and Acronyms Used
26. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 2: Global Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031
Table 3: Global Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 4: Global Intraosseous Infusion Devices Market Value (US$ Mn), Route of Administration, 2021 - 2031
Table 5: Global Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 6: Global Intraosseous Infusion Devices Market Value (US$ Mn), by Region, 2021 - 2031
Table 7: North America Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 8: North America Intraosseous Infusion Devices Market Volume (Mn units), by Product Segment, 2021 - 2031
Table 9: North America Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 10: North America Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 11: North America Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 12: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031
Table 13: Latin America Intraosseous Infusion Devices Market Volume (Mn units), by Country, 2021 - 2031
Table 14: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 15: Latin America Intraosseous Infusion Devices Market Volume (Mn units), by Product Segment, 2021 - 2031
Table 16: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 17: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 18: Latin America Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 19: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031
Table 20: Europe Intraosseous Infusion Devices Market Volume (Mn Units), by Country, 2021 - 2031
Table 21: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 22: Europe Intraosseous Infusion Devices Market Volume (Mn units), by Product Segment, 2021 - 2031
Table 23: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 24: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 25: Europe Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 26: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031
Table 27: South Asia Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031
Table 28: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 29: South Asia Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031
Table 30: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 31: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Automatic Technology Sub-Segment, 2021 - 2031
Table 32: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 33: South Asia Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 34: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031
Table 35: East Asia Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031
Table 36: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 37: East Asia Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031
Table 38: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 39: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 40: East Asia Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 41: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031
Table 42: Oceania Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031
Table 43: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 44: Oceania Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031
Table 45: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 46: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 47: Oceania Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Table 48: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Country, 2021 - 2031
Table 49: MEA Intraosseous Infusion Devices Market Volume (US$ Mn), by Country, 2021 - 2031
Table 50: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Product, 2021 - 2031
Table 51: MEA Intraosseous Infusion Devices Market Volume (Mn Units), by Product Segment, 2021 - 2031
Table 52: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Technology, 2021 - 2031
Table 53: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by Route of Administration, 2021 - 2031
Table 54: MEA Intraosseous Infusion Devices Market Value (US$ Mn), by End User, 2021 - 2031
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Intraosseous Infusion Devices Market Volume ('000 Units) Analysis, 2016-2020
Figure 2: Global Intraosseous Infusion Devices Market Volume ('000 Units) & Y-O-Y Growth (%) Analysis, 2021-2031
Figure 3: Global Average Pricing Analysis Benchmark USD (Unit)-2020
Figure 4: Global Intraosseous Infusion Devices Market Value (US% Mn) Analysis, 2016-2020
Figure 5: Global Intraosseous Infusion Devices Market Value (US% Mn) & Y-O-Y Growth (%) Analysis, 2021-2031
Figure 6: Global Intraosseous Infusion Devices Market Absolute $ Opportunity, 2021 - 2031
Figure 7: Global Intraosseous Infusion Devices Market Value Share, by Product, 2021 - 2031
Figure 8: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 9: Global Intraosseous Infusion Devices Market Value Share, by Technology, 2021 - 2031
Figure 10: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 11: Global Intraosseous Infusion Devices Market Value Share, by Route of administration, 2021 - 2031
Figure 12: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 13: Global Intraosseous Infusion Devices Market Value Share, by End User, 2021 - 2031
Figure 14: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 15: Global Intraosseous Infusion Devices Market Value Share, by Region, 2021 - 2031
Figure 16: Global Intraosseous Infusion Devices Market Attractiveness Analysis, by Region, 2021 - 2031
Figure 17: North America Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 18: North America Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 19: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 20: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 21: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 22: North America Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 23: Latin America Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 24: Latin America Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 25: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 26: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 27: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 28: Latin America Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 29: Europe Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 30: Europe Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 31: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031
Figure 32: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 33: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 34: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 35: Europe Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 36: South Asia Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 37: South Asia Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 38: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031
Figure 39: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 40: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 41: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 42: South Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 43: East Asia Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 44: East Asia Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 45: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031
Figure 46: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 47: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 48: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 49: East Asia Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 50: Oceania Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 51: Oceania Intraosseous Infusion Devices Market Value Share By Product, 2021 - 2031
Figure 52: Oceania Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 53: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 54: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 55: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 56: Oceania Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 - 2031
Figure 57: MEA Intraosseous Infusion Devices Market Value Share, by Country, 2021 - 2031
Figure 58: MEA Intraosseous Infusion Devices Market Absolute $ Opportunity (US$ Mn), 2021 - 2031
Figure 59: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Country, 2021 - 2031
Figure 60: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Product, 2021 - 2031
Figure 61: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Technology, 2021 - 2031
Figure 62: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by Route of Administration, 2021 - 2031
Figure 63: MEA Intraosseous Infusion Devices Market Attractiveness Analysis, by End User, 2021 – 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
